Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Utilize your home equity as a powerful tool to eliminate debt. Explore options that can help you regain financial stability.
23,247 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Paris Saint-Germain is testing a global lifestyle brand built on the idea that a football club can be more than its s...
Two financial plans, one patient retiree, and a surprising reframe: treating Social Security as a bond changes how a ...
NVIDIA faces growing pressure from customers exploiting cheaper compute options and in-house silicon, threatening its...
Hedge fund titan Ken Griffin challenges the AI hype, insisting the revolution is misunderstood and urging investors t...
IBM is attracting fresh investor attention as its AI infrastructure strategy gains traction. Arvind Krishna’s reshape...
Netflix is set to release its Q2 earnings after the bell tonight, with investors watching ad revenue growth, content ...
Lucid Group has faced years of volatility, but Saudi backing and a clearer product roadmap could shift the odds. This...
Tech giants push AI-led gains as the Nasdaq plays catch-up, with policy updates and earnings previews guiding a cauti...
Lemonade posted first positive GAAP free cash flow in the latest quarter, a milestone that reshapes the insurtech nar...
Broadcom is trading around $315, down about 9% year-to-date, as analysts push a $454 12-month target on accelerating ...
Bitcoin staged a striking break from a long-standing pattern, defying a rising dollar as ETF inflows surged. Analysts...